Growth Metrics

STRATA Skin Sciences (SSKN) Short term Debt (2013 - 2025)

STRATA Skin Sciences recorded quarterly Short term Debt of $15.3 million in Q4 2025, up 718.61% quarter-over-quarter from $1.9 million in Q3 2025.

STRATA Skin Sciences' Short term Debt history runs 10 years deep, the most recent figure standing at $15.3 million for Q4 2025.

  • In Q4 2025, Short term Debt changed N/A year-over-year to $15.3 million; the TTM figure through Dec 2025 stood at $15.3 million (changed N/A YoY), while the FY2025 annual figure was $15.3 million, changed N/A from the prior year.
  • Short term Debt came in at $15.3 million for Q4 2025 at STRATA Skin Sciences, up from $1.9 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $15.3 million in Q4 2025 to a low of $3000.0 in Q2 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 STRATA Skin Sciences - - 5.61 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 15.35 Mn
Sep 30, 2025 1.88 Mn
Jun 30, 2021 3,000.00
Mar 31, 2021 1.81 Mn
Dec 31, 2020 1.48 Mn
Sep 30, 2020 1.13 Mn
Jun 30, 2020 799,000.00
Sep 30, 2019 2.52 Mn
Jun 30, 2019 1.77 Mn
Mar 31, 2019 1.01 Mn
Dec 31, 2018 252,000.00
Sep 30, 2018 726,000.00
Mar 31, 2018 3.41 Mn
Dec 31, 2017 2.39 Mn
Sep 30, 2017 1.94 Mn
Jun 30, 2017 3.43 Mn
Mar 31, 2017 2.57 Mn
Dec 31, 2016 1.71 Mn
Sep 30, 2016 857,000.00
Sep 30, 2015 8.85 Mn
Jun 30, 2015 2.81 Mn
Sep 30, 2014 1.45 Mn
Jun 30, 2014 3.56 Mn
Mar 31, 2014 8.46 Mn
Dec 31, 2013 3.02 Mn
Jun 30, 2013 353,283.00